Skip to main content
Charles Pollack, MD, Emergency Medicine, Jackson, MS

CharlesVPollackMD

Emergency Medicine Jackson, MS

Clinician-Scientist, Department of Emergency Medicine, University of Mississippi School of Medicine, Jackson, MS

Dr. Pollack is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pollack's full profile

Already have an account?

  • Office

    2500 N State St
    Jackson, MS 39216
    Phone+1 610-329-2986
    Fax+1 888-959-8345

Education & Training

  • University of Mississippi Medical Center
    University of Mississippi Medical CenterResidency, Emergency Medicine, 1989 - 1992
  • Naval Medical Center (San Diego)
    Naval Medical Center (San Diego)Internship, Transitional Year, 1984 - 1985
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1984

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1992 - 2027
  • CA State Medical License
    CA State Medical License 1985 - 2026
  • MS State Medical License
    MS State Medical License 1989 - 2025
  • PA State Medical License
    PA State Medical License 2001 - 2024
  • DE State Medical License
    DE State Medical License 2015 - 2023
  • GA State Medical License
    GA State Medical License 1987 - 2021
  • NJ State Medical License
    NJ State Medical License 2015 - 2019
  • American Board of Emergency Medicine Emergency Medicine
  • Join now to see all

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACEP) American College of Emergency Physicians

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Idarucizumab for Dabigatran Reversal — Full Cohort AnalysisJuly 2017

Press Mentions

  • PhaseBio Pharmaceuticals to Host Investor Call to Discuss Interim Results from Pivotal REVERSE-IT Phase 3 Trial Presented at the American Heart Association Annual Meeting
    PhaseBio Pharmaceuticals to Host Investor Call to Discuss Interim Results from Pivotal REVERSE-IT Phase 3 Trial Presented at the American Heart Association Annual MeetingNovember 10th, 2021
  • FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board
    FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory BoardJuly 30th, 2019
  • Thromboprophylaxis Strategies in Acute Medically Ill Patients
    Thromboprophylaxis Strategies in Acute Medically Ill PatientsJuly 18th, 2019
  • Join now to see all

Professional Memberships